Filings For: Quince Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Quince Therapeutics, Inc. (QNCX) 8/25/2026 8:33:05 AM   View Proxy SEC Y 2025
Quince Therapeutics, Inc. (QNCX) 8/14/2026 4:24:24 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $123,995,000 EPS -$12.31
Quince Therapeutics, Inc. (QNCX) 8/14/2026 8:24:40 AM   View Financials Earnings SEC 2Q 2026 Assets $123,995,000 EPS -$12.31 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 5/11/2026 5:23:54 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $26,623,000 EPS $2.88
Quince Therapeutics, Inc. (QNCX) 4/27/2026 4:48:04 PM   View Proxy SEC Y 2025
Quince Therapeutics, Inc. (QNCX) 4/10/2026 4:46:11 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $93,523,000 EPS -$1.68
Quince Therapeutics, Inc. (QNCX) 2/12/2026 6:08:14 AM   View Financials Earnings (Prelim) SEC Y 2025 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 11/12/2025 4:16:55 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $109,899,000 EPS -$0.25
Quince Therapeutics, Inc. (QNCX) 11/12/2025 4:08:56 PM   View Financials Earnings SEC 3Q 2025 Assets $109,899,000 EPS -$0.25 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 8/11/2025 4:14:37 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $117,210,000 EPS -$0.34
Quince Therapeutics, Inc. (QNCX) 8/11/2025 4:07:14 PM   View Financials Earnings SEC 2Q 2025 Assets $117,210,000 EPS -$0.34 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 5/13/2025 8:51:53 AM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $107,089,000 EPS -$0.34
Quince Therapeutics, Inc. (QNCX) 5/13/2025 8:03:12 AM   View Financials Earnings SEC 1Q 2025 Assets $107,089,000 EPS -$0.34 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 4/23/2025 4:02:18 PM   View Proxy SEC Y 2024
Quince Therapeutics, Inc. (QNCX) 3/24/2025 4:14:18 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Assets $114,478,000 EPS -$1.31
Quince Therapeutics, Inc. (QNCX) 3/24/2025 4:09:25 PM   View Financials Earnings SEC Y 2024 Assets $114,478,000 EPS -$0.28 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 11/13/2024 5:24:56 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Assets $126,519,000 EPS -$0.13
Quince Therapeutics, Inc. (QNCX) 11/13/2024 4:16:46 PM   View Financials Earnings SEC 3Q 2024 Assets $126,519,000 EPS -$0.13 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 8/13/2024 4:29:34 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Assets $134,829,000 EPS -$0.64
Quince Therapeutics, Inc. (QNCX) 8/13/2024 4:11:55 PM   View Financials Earnings SEC 2Q 2024 Assets $134,829,000 EPS -$0.64 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 5/13/2024 7:47:32 AM Small View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Assets $159,292,000 EPS -$0.26
Quince Therapeutics, Inc. (QNCX) 5/13/2024 7:02:56 AM   View Financials Earnings WIRE 1Q 2024 Assets $159,292,000 EPS -$0.26 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 4/24/2024 4:02:17 PM   View Proxy SEC Y 2023
Quince Therapeutics, Inc. (QNCX) 4/1/2024 5:08:59 PM Small View Financials 10-K SEC Y 2023 ending: 12/31/2023 Assets $167,900,000 EPS -$0.84
Quince Therapeutics, Inc. (QNCX) 4/1/2024 7:01:59 AM   View Financials Earnings WIRE 1Q 2024 Assets $159,292,000 EPS -$0.26 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 11/14/2023 6:56:42 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Assets $85,386,000 EPS -$0.15
Quince Therapeutics, Inc. (QNCX) 8/3/2023 4:40:06 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Assets $88,836,000 EPS -$0.14
Quince Therapeutics, Inc. (QNCX) 7/24/2023 7:18:03 AM   View Presentation SEC Y 2023
Quince Therapeutics, Inc. (QNCX) 5/15/2023 4:44:59 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $93,318,000 EPS -$0.34
Quince Therapeutics, Inc. (QNCX) 4/14/2023 4:07:45 PM   View Proxy SEC Y 2022
Quince Therapeutics, Inc. (QNCX) 3/15/2023 4:38:32 PM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Assets $103,910,000 EPS -$1.54
Quince Therapeutics, Inc. (QNCX) 1/30/2023 4:21:45 PM   View Financials Earnings (Prelim) SEC Y 2022 Export Earnings Model
Quince Therapeutics, Inc. (QNCX) 11/9/2022 4:29:49 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $109,777,000 EPS -$0.22
Quince Therapeutics, Inc. (QNCX) 8/11/2022 4:05:55 AM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $117,863,000 EPS -$0.51
Cortexyme, Inc. (QNCX) 5/10/2022 5:09:57 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Assets $116,130,000 EPS -$0.72
Cortexyme, Inc. (QNCX) 4/27/2022 4:05:08 PM   View Proxy SEC Y 2021
Cortexyme, Inc. (QNCX) 3/1/2022 5:34:56 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Assets $133,228,000 EPS -$3.03
Cortexyme, Inc. (QNCX) 2/2/2022 5:04:10 PM   View Financials Earnings (Prelim) SEC Y 2021 Export Earnings Model
Cortexyme, Inc. (QNCX) 10/29/2021 9:12:45 AM Small View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Assets $147,416,000 EPS -$0.73
Cortexyme, Inc. (QNCX) 8/9/2021 8:04:19 AM   View Financials Earnings WIRE 2Q 2021 Assets $161,390,000 EPS -$0.74 Export Earnings Model
Cortexyme, Inc. (QNCX) 8/6/2021 4:35:21 PM Small View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Assets $161,390,000 EPS -$0.74
Cortexyme, Inc. (QNCX) 5/10/2021 8:36:22 AM   View Financials Earnings WIRE 1Q 2021 Assets $174,522,000 EPS -$0.78 Export Earnings Model
Cortexyme, Inc. (QNCX) 5/6/2021 4:31:34 PM Small View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Assets $174,522,000 EPS -$0.78
Cortexyme, Inc. (QNCX) 4/30/2021 6:09:03 AM   View Proxy SEC Y 2020
Cortexyme, Inc. (QNCX) 3/1/2021 4:35:02 PM Small View Financials 10-K SEC Y 2020 ending: 12/31/2020 Assets $189,466,000 EPS -$2.63
Cortexyme, Inc. (QNCX) 1/26/2021 8:21:20 AM   View Financials Earnings (Prelim) SEC Y 2020 Export Earnings Model
Cortexyme, Inc. (QNCX) 11/12/2020 4:31:10 PM   View Financials Earnings WIRE 3Q 2020 Assets $204,664,000 EPS -$0.73 Export Earnings Model
Cortexyme, Inc. (QNCX) 11/12/2020 4:26:23 PM Small View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $204,664,000 EPS -$0.73
Cortexyme, Inc. (QNCX) 8/17/2020 8:04:37 AM   View Financials Earnings WIRE 2Q 2020 Assets $219,210,000 EPS -$0.60 Export Earnings Model
Cortexyme, Inc. (QNCX) 8/14/2020 4:35:01 PM Small View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Assets $219,210,000 EPS -$0.60
Cortexyme, Inc. (QNCX) 5/12/2020 4:47:07 PM   View Financials Earnings SEC 1Q 2020 Assets $231,205,000 EPS -$0.61 Export Earnings Model
Cortexyme, Inc. (QNCX) 5/12/2020 4:21:45 PM Small View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Assets $231,205,000 EPS -$0.61
Cortexyme, Inc. (QNCX) 4/22/2020 3:27:28 PM   View Proxy SEC Y 2019
Cortexyme, Inc. (QNCX) 3/17/2020 1:26:42 PM   View Financials Earnings SEC Y 2019 Assets $124,370,000 EPS -$0.35 Export Earnings Model
Cortexyme, Inc. (QNCX) 3/16/2020 4:22:53 PM Micro View Financials 10-K SEC Y 2019 ending: 12/31/2019 Assets $124,370,000 EPS -$1.94
Cortexyme, Inc. (QNCX) 11/12/2019 5:05:35 PM Micro View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Assets $133,414,000 EPS -$0.37
Cortexyme, Inc. (QNCX) 11/12/2019 4:08:39 PM   View Financials Earnings WIRE 3Q 2019 Assets $133,414,000 EPS -$0.37 Export Earnings Model
Cortexyme, Inc. (QNCX) 8/9/2019 4:33:54 PM Micro View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Assets $143,242,000 EPS -$0.57
Cortexyme, Inc. (QNCX) 6/12/2019 5:06:25 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Assets $70,596,000 EPS -$1.61